Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Wheeler

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Opinion in Nephrology and Hypertension|November 18, 1998
Statins and the kidneyD C Wheeler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 1999
Ischaemic heart disease after renal transplantation: how to assess and minimize the riskD C Wheeler
Journal of Nephrology|January 19, 2002
Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statinsD C Wheeler
Kidney International. Supplement|November 1, 1996
Abnormalities of lipoprotein metabolism in CAPD patientsD C Wheeler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Lipids--what is the evidence for their role in progressive renal disease?D C Wheeler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
Should hyperlipidaemia in dialysis patients be treated?D C Wheeler
Drugs|November 7, 1998
Are there potential non-lipid-lowering uses of statins?D C Wheeler
Lancet (London, England)|December 21, 1996
Cardiovascular disease in patients with chronic renal failureD C Wheeler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2000
Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure?C Baigent, D C Wheeler
Journal of the Royal Society of Medicine|June 9, 2000
Lipid abnormalities in renal diseaseA Majumdar, D C Wheeler
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Opinion in Nephrology and Hypertension|November 18, 1998
Statins and the kidneyD C Wheeler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 1999
Ischaemic heart disease after renal transplantation: how to assess and minimize the riskD C Wheeler
Journal of Nephrology|January 19, 2002
Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statinsD C Wheeler
Kidney International. Supplement|November 1, 1996
Abnormalities of lipoprotein metabolism in CAPD patientsD C Wheeler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Lipids--what is the evidence for their role in progressive renal disease?D C Wheeler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
Should hyperlipidaemia in dialysis patients be treated?D C Wheeler
Drugs|November 7, 1998
Are there potential non-lipid-lowering uses of statins?D C Wheeler
Lancet (London, England)|December 21, 1996
Cardiovascular disease in patients with chronic renal failureD C Wheeler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2000
Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure?C Baigent, D C Wheeler
Journal of the Royal Society of Medicine|June 9, 2000
Lipid abnormalities in renal diseaseA Majumdar, D C Wheeler
Pageof 7